To achieve capital growth through investing in high growth, development stage biotechnology companies.
Find out MoreInt.biotech. Share Price | |
---|---|
Price | 650.00 |
Bid | 0.00 |
Ask | 0.00 |
Change | 0.00 (0.00%) |
Volume | 0 |
Open | 0.00 |
High | 0.00 |
Low | 0.00 |
Prev. Close | 650.00 |
Currency | GBX |
---|---|
Issue Country | GB |
Shares in Issue | 38.09m |
Market Capitalisation | £247.60m |
Market Size | 750 |
52 Week High | 704.00 |
52 Week High Date | 28-Feb-2024 |
52 Week Low | 548.00 |
52 Week Low Date | 27-Oct-2023 |
# Trades | 0 |
---|---|
Vol. Sold | 0 |
Sold Value | £N/A |
Vol. Bought | 0 |
Bought Value | £N/A |
PE Ratio | 38.71352 |
Earnings | 16.79 |
Dividend | 28.20 |
Yield | 4.338% |
Date | Time | Trade Prc | Volume | Buy/Sell | Bid | Ask | Value | |
---|---|---|---|---|---|---|---|---|
18-Mar-24 | 16:47:38 | 658.6581 | 7,042 | Unknown* | 652.00 | 656.00 | 46.38k | O Ordinary Non protected portfolio Single protected transaction |
18-Mar-24 | 16:35:25 | 650.00 | 85 | Sell* | 652.00 | 656.00 | 552.50 | UT Uncrossing Trade |
18-Mar-24 | 16:17:15 | 652.00 | 57 | Sell* | 652.00 | 656.00 | 371.64 | A Automatic Execution |
18-Mar-24 | 16:17:02 | 654.00 | 150 | Buy* | 652.00 | 654.00 | 981.00 | A Automatic Execution |
18-Mar-24 | 16:17:02 | 654.00 | 600 | Buy* | 652.00 | 654.00 | 3,924 | A Automatic Execution |
18-Mar-24 | 16:12:40 | 654.00 | 35 | Buy* | 652.00 | 654.00 | 228.90 | A Automatic Execution |
18-Mar-24 | 16:12:40 | 654.00 | 150 | Buy* | 652.00 | 654.00 | 981.00 | A Automatic Execution |
18-Mar-24 | 16:11:37 | 654.00 | 600 | Buy* | 652.00 | 654.00 | 3,924 | A Automatic Execution |
18-Mar-24 | 16:11:19 | 654.00 | 450 | Sell* | 654.00 | 656.00 | 2,943 | A Automatic Execution |
18-Mar-24 | 16:11:18 | 654.00 | 150 | Buy* | 652.00 | 654.00 | 981.00 | A Automatic Execution |
Announced | Traded | Action | Notifier | Price | Currency | Amount | Holding |
---|---|---|---|---|---|---|---|
07-Nov-23 | 07-Nov-23 | Buy | Caroline Gulliver held the position of Independent Non-Executive Director at the time of this trade.Caroline Gulliver | 573.15 | GBX | 2,500 | 17,000 |
04-Aug-23 | 03-Aug-23 | Buy | Patrick Magee held the position of Independent Non-Executive Director at the time of this trade.Patrick Magee | 632.00 | GBX | 1,500 | 11,500 |
03-Aug-23 | 03-Aug-23 | Buy | Katherine Cornish-Bowden held the position of Senior Independent Director at the time of this trade.Katherine Cornish-Bowden | 633.18 | GBX | 1,500 | 12,500 |
11-May-22 | 11-May-22 | Buy | Patrick Maxwell held the position of Independent Non-Executive Director at the time of this trade.Patrick Maxwell | 589.35 | GBX | 3,725 | 3,725 |
01-Apr-22 | 01-Apr-22 | Buy | Patrick Magee held the position of Independent Non-Executive Director at the time of this trade.Patrick Magee | 633.00 | GBX | 2,500 | 10,000 |